# Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study

> **NCT01385319** · PHASE3 · UNKNOWN · sponsor: **Marco Valgimigli** · enrollment: 1606 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Bare metal stent implantation
- **DEVICE:** zotarolimus eluting stent

## Key facts

- **NCT ID:** NCT01385319
- **Lead sponsor:** Marco Valgimigli
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-06
- **Primary completion:** 2012-09
- **Final completion:** 2017-12
- **Target enrollment:** 1606 (ACTUAL)
- **Last updated:** 2012-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01385319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01385319, "Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01385319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*